Thank you for contacting me about booster doses of COVID-19 vaccine for asthma patients.
The Joint Committee on Vaccination and Immunisation (JCVI) concluded that only those with more severe forms of asthma are at clinically high risk from COVID-19. This group are defined as adults with asthma who require continuous or repeated use of systemic steroids or with previous exacerbations requiring hospital admission and will have been eligible for vaccination as part of priority group six. An individual with a more severe case of asthma may have been included in the clinically extremely vulnerable group, in which case they will have been eligible as part of priority group four.
Continued on PDF below...